To qualitatively and quantitatively define RON- and DEK-dependent reprogramming of lipid metabolites, NMR spectroscopy was applied to R7 breast cancer cells and the corresponding RON or DEK knockdown cell lines. The gene discussed is DEK; the disease is breast carcinoma.